Showing results (181-190 of 676) with videos related to
Sort By:
Pageof 68
Clinical Advances in Hematology & Oncology : H&O|July 17, 2009
Pentostatin treatment combinations in chronic lymphocytic leukemiaNicole Lamanna, Neil E KayClinical Advances in Hematology & Oncology : H&O|August 28, 2009
Clinical roundtable monograph. Overall survival and maintenance of MDS patientsLewis R SilvermanClinical Advances in Hematology & Oncology : H&O|September 8, 2021
Management of well-differentiated neuroendocrine tumorsSri Harsha Tella, Jason S Starr, Anuhya Kommalapati, et al.Clinical Advances in Hematology & Oncology : H&O|May 14, 2021
Lenalidomide in DLBCL: are we past the cell of origin?Mendel Goldfinger, Dennis L CooperClinical Advances in Hematology & Oncology : H&O|February 13, 2023
A review of essential thrombocythemia and its complicationsRodrick Babakhanlou, Lucia Masarova, Srdan VerstovsekClinical Advances in Hematology & Oncology : H&O|December 9, 2016
Highlights in polycythemia vera from the 2016 EHA congressSrdan VerstovsekClinical Advances in Hematology & Oncology : H&O|December 9, 2016
Immunotherapy for the treatment of breast cancer: checkpoint blockade, cancer vaccines, and future directions in combination immunotherapyHeather L McArthur, David B PageClinical Advances in Hematology & Oncology : H&O|September 28, 2016
Cytoreductive nephrectomy for metastatic renal cell carcinomaLisly J Chery, Jose A Karam, Christopher G WoodClinical Advances in Hematology & Oncology : H&O|September 28, 2016
The status of poly(adenosine diphosphate-ribose) polymerase (PARP) inhibitors in ovarian cancer, part 2: extending the scope beyond olaparib and BRCA1/2 mutationsRowan E Miller, Jonathan A LedermannClinical Advances in Hematology & Oncology : H&O|February 13, 2014
Treatment paradigms in advanced non-small-cell lung cancerCaroline E McCoach, Karen KellyPageof 68